2024-09-19 |
Postoperative Management of Prostate Cancer |
|
|
2024-09-19 |
More Benefits of Tai Chi Than Aerobic Exercise in Patients With Advanced Lung Cancer—Reply |
|
|
2024-09-19 |
Waterpipe Tobacco Smoking and Risk of Cancer Mortality |
|
|
2024-09-19 |
Measurable Residual Disease and Outcomes in Chronic Lymphocytic Leukemia |
|
|
2024-09-19 |
Advancing Genomic Cancer Medicine in Rural and Underserved States |
|
|
2024-09-19 |
Chemotherapy, Radiation Therapy, and Nasopharyngeal Carcinoma |
|
|
2024-09-19 |
B-Cell Maturation Antigen/CD19 Dual-Targeting Immunotherapy in Newly Diagnosed Multiple Myeloma |
|
|
2024-09-19 |
Exercise For Prostate Cancer |
|
|
2024-09-19 |
Characterizing Lung Cancer in Li-Fraumeni Syndrome |
|
|
2024-09-19 |
Recurrence of Non–Small Cell Lung Cancer With Visceral Pleural Invasion |
|
|
2024-09-19 |
Sublobar Resection vs Lobectomy for High-Risk Stage I Non–Small Cell Lung Carcinoma |
|
|
2024-09-19 |
Error in Author Affiliations |
|
|
2024-09-19 |
JAMA Oncology |
|
|
2024-09-19 |
Sexual Rehabilitation Needs of Gay and Bisexual Men With Cancer |
|
|
2024-09-19 |
Contralateral Breast Cancer Remains a Complex Biological Conundrum |
|
|
2024-09-19 |
Error in Abstract |
|
|
2024-09-19 |
Immunotherapy Before Chemoradiotherapy—More Is Better? |
|
|
2024-09-19 |
Neoadjuvant Exercise Therapy in Prostate Cancer |
|
|
2024-09-19 |
Population-Based Incidence of Cervical Intraepithelial Neoplasia Across 14 Years of HPV Vaccination |
|
|
2024-09-19 |
Chemotherapy, Radiation Therapy, and Nasopharyngeal Carcinoma |
|
|
2024-09-19 |
Atezolizumab Before and After Chemoradiation for Unresectable Stage III NSCLC |
|
|
2024-09-19 |
Chemotherapy, Radiation Therapy, and Nasopharyngeal Carcinoma—Reply |
|
|
2024-09-19 |
Bintrafusp Alfa for Recurrent or Metastatic Cervical Cancer After Platinum Failure |
|
|
2024-09-19 |
Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma |
|
|
2024-09-19 |
Bilateral Mastectomy and Breast Cancer Mortality |
|
|
2024-09-19 |
Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer |
|
|
2024-09-19 |
Cara |
|
|
2024-09-19 |
More Benefits of Tai Chi Than Aerobic Exercise in Patients With Advanced Lung Cancer |
|
|
2024-09-19 |
BRCA1, BRCA2 , and Associated Cancer Risks and Management for Male Patients |
|
|
2024-09-19 |
A Case of Gastric Thickening and a Large Ovarian Mass |
|
|
2024-09-19 |
Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction |
|
|
2024-09-19 |
Assessing the Environmental and Downstream Human Health Impacts of Decentralizing Cancer Care |
|
|
2024-09-19 |
Error in Figure 1 |
|
|
2024-08-15 |
Lymphoma With a Skin Rash |
|
|
2024-08-15 |
Immunotherapy For US Patients With Metastatic Cancer at the End of Life—Reply |
|
|
2024-08-15 |
Valid Analysis of Brain-Specific Progression-Free Survival |
|
|
2024-08-15 |
Valid Analysis of Brain-Specific Progression-Free Survival—Reply |
|
|
2024-08-15 |
Performance of Tumor Surveillance for Children With Cancer Predisposition |
|
|
2024-08-15 |
Piercing the Fog |
|
|
2024-08-15 |
Caregiver Burden—Within and Without |
|
|
2024-08-15 |
Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer |
|
|
2024-08-15 |
Adjuvant Chemotherapy and Chemoradiation in Gallbladder Cancer |
|
|
2024-08-15 |
Pancreatic Cancer Surveillance and Survival |
|
|
2024-08-15 |
Error in Byline |
|
|
2024-08-15 |
Errors in Table |
|
|
2024-08-15 |
JAMA Oncology |
|
|
2024-08-15 |
Geographic Distribution of Clinical Trials for Advanced-Stage Cancer |
|
|
2024-08-15 |
Fluorine-18 PSMA-1007 PET/CT vs Multiparametric MRI for Locoregional Staging of Prostate Cancer |
|
|
2024-08-15 |
Change to Open Access |
|
|
2024-08-15 |
Long-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer |
|
|
2024-08-15 |
Survival in Patients With Recurrent Intermediate-Stage Hepatocellular Carcinoma |
|
|
2024-08-15 |
Optimal Preventive Strategy for Breast Radiation Dermatitis |
|
|
2024-08-15 |
Postrecurrence Treatment in Neoadjuvant or Adjuvant FDA Registration Trials |
|
|
2024-08-15 |
Comprehensive Risk Stratification to Guide an Optimal Preventive Strategy for Breast Radiation Dermatitis—Reply |
|
|
2024-08-15 |
Current Management of Desmoid Tumors |
|
|
2024-08-15 |
Endometrial Thickness as Diagnostic Triage for Endometrial Cancer in Black Individuals |
|
|
2024-08-15 |
Valid Analysis of Brain-Specific Progression-Free Survival |
|
|
2024-08-15 |
Tumor-Infiltrating Lymphocytes in Stage I TNBC Untreated With Chemotherapy |
|
|
2024-08-15 |
Home Time in Older Adults With AML |
|
|
2024-08-15 |
Assessing the Evidence for Circulating Tumor HPV DNA in Patients With Oropharyngeal Cancer |
|
|
2024-08-15 |
Immunotherapy For US Patients With Metastatic Cancer at the End of Life |
|
|
2024-08-15 |
Advancing Precision Equity With Multicancer Detection Liquid Biopsies |
|
|
2024-08-15 |
Radiation With Immunotherapy May Be a Double-Edged Sword |
|
|
2024-08-15 |
The Sequencing Conundrum in Localized Pancreatic Adenocarcinoma |
|
|
2024-08-15 |
Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia |
|
|
2024-08-15 |
Error in the Abstract |
|
|
2024-07-18 |
Dose-Adjusted EPOCH Plus Inotuzumab Ozogamicin for Adult Relapsed or Refractory B-Cell ALL |
|
|
2024-07-18 |
Watch and Wait for Near-Complete Responders |
|
|
2024-07-18 |
Physician and AI Responses to Cancer Questions |
|
|
2024-07-18 |
Systemic Anticancer Therapy and Overall Survival in Patients With Very Advanced Solid Tumors |
|
|
2024-07-18 |
Community Health Care Workers Empowering Advance Care Planning |
|
|
2024-07-18 |
Reirradiation Therapy With Nivolumab for Head and Neck Cancer |
|
|
2024-07-18 |
Cardiovascular Events in Prostate Cancer Treated With Novel ARSI |
|
|
2024-07-18 |
JAMA Oncology |
|
|
2024-07-18 |
Comprehensive Audiologic Analyses After Cisplatin-Based Chemotherapy |
|
|
2024-07-18 |
Neoadjuvant Nivolumab Plus Chemotherapy and Response-Adaptive Therapy for HPV + Oropharyngeal Cancer |
|
|
2024-07-18 |
Cardiovascular Risk in Prostate Cancer |
|
|
2024-07-18 |
Stereotactic Ablative Radiotherapy for Gynecological Oligometastatic and Oligoprogessive Tumors |
|
|
2024-07-18 |
Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Lung Cancer |
|
|
2024-07-18 |
Genetic Testing in Men With mCRPC |
|
|
2024-07-18 |
Climate Change in Comprehensive Cancer Control Plans in the US |
|
|
2024-07-18 |
Longer Interval Between First Colonoscopy and Repeat Colonoscopy |
|
|
2024-07-18 |
Results of the TARGET-TP Randomized Clinical Trial |
|
|
2024-07-18 |
A Patient With Slow Communication and Difficulty Walking |
|
|
2024-07-18 |
Umbilical Cord–Derived Mesenchymal Stromal Cells For Prevention of Chronic Graft-vs-Host Disease |
|
|
2024-07-18 |
Intrathecal Trastuzumab-Pertuzumab After RT for ERBB2-Positive Breast LMD |
|
|
2024-07-18 |
Results of the TARGET-TP Randomized Clinical Trial |
|
|
2024-07-18 |
Predictions |
|
|
2024-07-18 |
Results of the TARGET-TP Randomized Clinical Trial—Reply |
|
|
2024-07-18 |
Axillary Surgery for Chemoresidual (ypN-Positive) Nodal Disease |
|
|
2024-07-18 |
Umbilical Cord–Derived Mesenchymal Stromal Cells For Prevention of Chronic Graft-vs-Host Disease—Reply |
|
|
2024-07-18 |
Dual Checkpoint Inhibition in Melanoma With ≥1% PD-L1—Time to Reassess the Evidence |
|
|
2024-07-18 |
Long-Term Engagement of Patients With Advanced Cancer |
|
|
2024-07-18 |
Comprehensive Bridging Radiotherapy for Limited Pre-CART Non-Hodgkin Lymphoma |
|
|
2024-07-18 |
Snapshots From My Staycay With Chemo |
|
|
2024-07-18 |
The Interval for Screening Colonoscopy—Is 15 the New 10? |
|
|
2024-07-18 |
Obstacles to Biosimilar Acceptance and Uptake in Oncology |
|
|
2024-07-18 |
Substance Use Disorders Among Cancer Survivors |
|
|
2024-07-18 |
Coaches Activating, Reaching, and Engaging Patients to Engage in Advance Care Planning |
|
|
2024-07-18 |
The Ethics of Artificial Empathy |
|
|